Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)
Packaging methods help limit contact with moisture, light, and temperature fluctuations that could affect peptide stability
We also measured intracellular GSH concentrations, reactive oxygen metabolites, and lipid peroxides
The report appeared only a week after 81 members of the House of Representatives sent a letter to the FDA urging a crackdown on counterfeit anti-obesity medications entering the U.S
Now its time to see what we can do for you
The fragmentation that defines Act 2 of the GLP-1 era is not a marketing artifact or a pipeline accident
